Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boulton, A. J.
Right arrow Articles by Ward, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boulton, A. J.
Right arrow Articles by Ward, J. D.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 8, Issue 2 125-128, Copyright © 1985 by American Diabetes Association

ARTICLES

The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population

AJ Boulton, G Knight, J Drury and JD Ward

The prevalence of symptomatic sensorimotor polyneuropathy has been determined in a population of 382 insulin-treated diabetic subjects aged 15-59 yr. Forty-one subjects (10.7%) were found to have diabetic neuropathy, according to strict diagnostic criteria that required the presence of symptoms and signs of nerve dysfunction in the absence of peripheral vascular disease. There was a significant correlation between glycosylated hemoglobin levels and motor conduction velocity in the median and peroneal nerves in all subjects. This finding further emphasizes the importance of metabolic factors related to hyperglycemia in the impaired nerve function seen in diabetic patients.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 BMJHome page
M.-c. Wong, J. W Y Chung, and T. K S Wong
Effects of treatments for symptoms of painful diabetic neuropathy: systematic review
BMJ, July 14, 2007; 335(7610): 87 - 87.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
C. F. Corbett
Practical Management of Patients With Painful Diabetic Neuropathy
The Diabetes Educator, July 1, 2005; 31(4): 523 - 540.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. J.M. Boulton, R. A. Malik, J. C. Arezzo, and J. M. Sosenko
Diabetic Somatic Neuropathies
Diabetes Care, June 1, 2004; 27(6): 1458 - 1486.
[Full Text] [PDF]

Home page
 QJMHome page
D.K. Kochar, N. Rawat, R.P. Agrawal, A. Vyas, R. Beniwal, S.K. Kochar, and P. Garg
Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study
QJM, January 1, 2004; 97(1): 33 - 38.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
Y. Matsuka and I. Spigelman
Hyperosmolar Solutions Selectively Block Action Potentials in Rat Myelinated Sensory Fibers: Implications for Diabetic Neuropathy
J Neurophysiol, January 1, 2004; 91(1): 48 - 56.
[Abstract] [Full Text]

Home page
 Diabetes CareHome page
J. R. Larsen, H. Sjoholm, K. F. Hanssen, L. Sandvik, T. J. Berg, and K. Dahl-Jorgensen
Optimal Blood Glucose Control During 18 Years Preserves Peripheral Nerve Function in Patients With 30 Years' Duration of Type 1 Diabetes
Diabetes Care, August 1, 2003; 26(8): 2400 - 2404.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
S. M. Cohen and T. Mathews
Pentoxifylline in the Treatment of Distal Diabetic Neuropathy
Angiology, September 1, 1991; 42(9): 741 - 746.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1985 by the American Diabetes Association.